Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 5Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1

Conditions

Myelodysplastic Syndromes 211Leukemia, Myeloid, Acute 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 162Leukemia 125Lymphoma, Non-Hodgkin 112Hodgkin Disease 102Leukemia, Lymphocytic, Chronic, B-Cell 99Multiple Myeloma 97Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Lymphoma 88Myeloproliferative Disorders 87Lymphoma, Follicular 72Leukemia, Myelomonocytic, Chronic 72Leukemia, Myeloid, Chronic-Phase 71Lymphoma, Mantle-Cell 70Burkitt Lymphoma 67Leukemia, Myeloid, Accelerated Phase 65Primary Myelofibrosis 62Lymphoma, B-Cell, Marginal Zone 61Lymphoma, Large B-Cell, Diffuse 60Blast Crisis 53Anemia, Refractory, with Excess of Blasts 51Lymphoma, Large-Cell, Immunoblastic 50Congenital Abnormalities 50Neoplasms, Plasma Cell 47Myelodysplastic-Myeloproliferative Diseases 45Dendritic Cell Sarcoma, Interdigitating 41Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 38Graft vs Host Disease 38Leukemia, Biphenotypic, Acute 37

Interventions

ripretinib 1pevonedistat 1Cyclophosphamide 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Cyclophosphamide × Myeloid × Clear all
NCT02360111 2019-07-24

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
3 enrolled 6 charts
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡